Vitamin D and Microbiota: Two Sides of the Same Coin in the Immunomodulatory Aspects
Overview
Pharmacology
Authors
Affiliations
The gut microbiota is crucial for host immune response, vitamin synthesis, short chain fatty acids (SCFAs) production, intestinal permeability, nutrient digestion energy metabolism and protection from pathogens. Therefore, gut microbiota guarantees the host's predisposition to gastrointestinal diseases. Intestinal microbiota may be damaged by environmental components with negative health conditions. Dysbiosis consisting in alteration in the gut microbiota has been involved in several disorders including inflammation, allergic reactions, autoimmune diseases, heart diseases, obesity, and metabolic syndrome and even in the state of malignant carcinogenesis existing in humans. Several epidemiological studies have shown that inadequate solar exposure results in vitamin D insufficiency/deficiency which has a strong impact on different immune responses and the occurrence of a wide range of pathological conditions. Additionally, new evidence indicates that the vitamin D pathway plays a key role in gut homeostasis. Due to the strong connection between vitamin D and microbiota, herein we focus on the new findings about intestinal bacteria-immune crosstalk and the impact of vitamin D in gut microbiota regulation, in order to offer new clarifications on their interaction. Understanding the mechanism by which vitamin D can affect the gut microbiota composition and its dynamic activities, as well as the innate and adaptive state of the immune system, is not only a fundamental research but also an opportunity to improve health status.
Role of innate immunity in SARS-CoV-2 infection.
Wang Z, Cheng F, Xu Y, Li X, Meng S Biosaf Health. 2025; 5(5):280-288.
PMID: 40078906 PMC: 11894970. DOI: 10.1016/j.bsheal.2023.08.005.
Manole A, Marcut L, Carciumaru R, Manole F Diagnostics (Basel). 2025; 15(5).
PMID: 40075767 PMC: 11898411. DOI: 10.3390/diagnostics15050519.
The Gut Microbiota Involvement in the Panorama of Muscular Dystrophy Pathogenesis.
Russo C, Surdo S, Valle M, Malaguarnera L Int J Mol Sci. 2024; 25(20).
PMID: 39457092 PMC: 11508360. DOI: 10.3390/ijms252011310.
Bioactive metabolites: A clue to the link between MASLD and CKD?.
Chen W, Zhang J, Chen L, Byrne C, Targher G, Luo L Clin Mol Hepatol. 2024; 31(1):56-73.
PMID: 39428978 PMC: 11791555. DOI: 10.3350/cmh.2024.0782.
Zakerska-Banaszak O, Zuraszek-Szymanska J, Eder P, Ladziak K, Slomski R, Skrzypczak-Zielinska M Int J Mol Sci. 2024; 25(17).
PMID: 39273536 PMC: 11394875. DOI: 10.3390/ijms25179589.